Sino-Singapore Jingwei, May 27th. After the close of May 27th,Zhongtong Bus(13.47 +8.54%,diagnostic stock) received a letter of concern from the Shenzhen Stock Exchange, requesting to verify the company's controlling shareholder, actual controller, directors, supervisors and senior managers Whether or not their immediate family members have traded the company's stock, and whether there is suspected insider trading.
On May 27, Zhongtong Bus hit the daily limit again, walked out of 11 consecutive boards, reported 12.41 yuan per share, and the turnover exceeded 700 million yuan.It has risen by 185.94% in 11 trading days.
Source of K-line chart of Zhongtong Bus stock price:Flush(82.79 +0.35%,diagnostic stock) iFind
The continuous risein stock prices has also attracted the attention of the Shenzhen Stock Exchange.The letter of concern requires that it confirm whether there is any material information that should be disclosed but has not been disclosed, whether the company’s fundamentals have undergone major changes, and take into account the major risks faced by the company’s production and operation recently, as well as stock price trends and changes in valuation, etc. risk warning.
According to the letter of concern, according to relevant regulations, the Shenzhen Stock Exchange has sent a written inquiry to the company's controlling shareholder and actual controller, stating whether the company's controlling shareholder and actual controller plan to carry out equity transfer,asset restructuringand other matters that have a significant impact on your company. , and asked for a written response.
The letter of concern requires, in accordance with relevant regulations, to detail the recent surveys of institutions and individual investors received, whether the company's unpublishedannual reportinformation is provided to third parties other than the annual audit accounting firm, and whether there is any violation of fair disclosure of information.Check whether the company's controlling shareholder, actual controller, directors, supervisors, senior managers and their immediate family members have bought or sold your company's stock, and whether there is suspected insider trading.
In addition, the letter of concern pointed out that recently.There is content related to the company's nucleic acid detection vehicle business on the Interactive Easy Platform.
On May 10, Zhongtong Bus stated on the investor interaction platform that the company currently has two medical vehicles that can be used for nucleic acid testing.At present, the company's products sold in batches include two nucleic acid detection vehicles of 12 meters and 13 meters, all of which meet the P2+ biosafety laboratory standard, equipped with medical-specific air conditioning systems, equipped with high-efficiency fresh air filtration systems, medical water supply and drainage systems, and automatic PCR analysis. system, 5G signal transmission, etc., with the functions of on-the-fly acquisition, on-the-fly inspection, and on-the-fly reporting.
Source: Shenzhen Stock Exchange Interactive Easy
According to the requirements of the letter of concern, please describe the company's nucleic acid testing vehicle business scale and its impact on the company's business development and profitability in combination with the company's nucleic acid testing vehicle production, revenue amount, proportion, orders in hand, etc.; list analysis of the company from 2022 to the present The composition of main products, including but not limited to main products, models, output, sales volume, corresponding operating income and its proportion, etc., and indicate whether industry policies that have a significant impact on the company have been introduced recently.
In terms of performance, in the first quarter of 2022, Zhongtong Bus achieved operating income of 863 million yuan, a year-on-year increase of 30.93%; the net loss attributable to shareholders of thelisted companywas 35.287 million yuan.In 2021, the company achieved operating income of 4.587 billion yuan, a year-on-year increase of 4.06%, and a net loss of 220 million yuan attributable to shareholders of listed companies.(Sino-Singapore Jingwei APP)
